I don't know if you saw this. It's a little old but interesting. Check out Onocology Intelligence Report February 4th .
First time I've seen information that says the analysis was underestimating Vosaroxin's efficacy. Looks very promising. Thanks for the info. Sometimes this board works the way it should. Unbiased information from a reliable source!
Sentiment: Strong Buy